Myristoyl coenzyme A (lithium)
Myristoyl coenzyme A lithium is lithium-labeled myristoylated coenzyme A (CoA) . Myristoylation is an essential process in viruses and is generally controlled by N-myristoyltransferase (NMT) . And NMT is more active in colon epithelial tumors than in normal cells. Reduced Ccoenzyme A (CoA) is known to be a key regulator of NMT activity, whereas oxidized CoA does not allow NMT to promote myristoylation. Myristoyl coenzyme A blocks the demyristoylation process and has potential anticancer and antiviral mechanisms.
Product Specifications
CAS Number
187100-75-0
UNSPSC
12352005
Target
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Cancer; Infection
Assay Protocol
https://www.medchemexpress.com/myristoyl-coenzyme-a-lithium.html
Purity
97.0
Solubility
10 mM in DMSO
Smiles
O=C(SCCNC(CCNC([C@H](O)C(C)(C)COP(OP(OC[C@@H]1[C@@H](OP(O)(O)=O)[C@@H](O)[C@]([H])(N2C=NC3=C(N)N=CN=C32)O1)(O)=O)(O)=O)=O)=O)CCCCCCCCCCCCC.[Li].[x]
Molecular Formula
C35H62N7O17P3S.xLi
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Human Endogenous Metabolite
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD50 / ICAM3 (CG106), CF594 conjugate, 0.1mg/mL
Glypican-3 (GPC3/863), CF640R conjugate, 0.1mg/mL
CD43 (T-Cell Marker) (SPN/2049R), CF405S conjugate, 0.1mg/mL
Nucleolin (364-5 + NCL/902), CF740 conjugate, 0.1mg/mL
